|
|
|
Control |
Cancer |
p value |
Biomarker |
Units |
Serum/ plasma |
median (range) |
median (range) |
cancer vs control |
|
|
|
|
all cancers |
|
PKM2 |
U/ml |
plasma |
21.02 (11.26 - 73.3) |
30.71 (5.81 - 98.80) |
0.0006 |
IL8 |
pg/ml |
serum |
11.26 (4.36 - 49.89) |
15.77 (3.71 - 103.5) |
0.0006 |
IL6 |
pg/ml |
serum |
1.84 (0.95 - 55.80) |
1.355 (0.93 - 4.740) |
0.0006 |
IGFBP2 |
ng/ml |
serum |
490.5 (188.7 - 1583) |
699.2 (163.3 - 3698) |
0.0011 |
Mac2BP |
ng/ml |
serum |
7126 (3918 - 20150) |
8350 (4290 - 40870) |
0.0012 |
VEGFA |
pg/ml |
plasma |
48.69 (31.42 - 387) |
78.96 (33.29 - 910.1) |
0.0013 |
TGFB1 |
pg/ml |
plasma |
6034 (2070 - 21122) |
8794 (1846 - 64230) |
0.005 |
M65 |
U/L |
serum |
312.6 (143.3 - 783.2) |
358.4 (132.8 - 1032) |
0.0051 |
IGF2 |
ng/ml |
serum |
1399 (792.3 - 2230) |
1221 (421.1 - 1864) |
0.0052 |
TIMP1 |
ng/ml |
plasma |
74.89 (42.53 - 131.3) |
84.31(49.9 - 359.6) |
0.0062 |
TIMP1 |
ng/ml |
serum |
172.8 (74.3 - 314.4) |
193.8 (98.6-449.4) |
0.0129 |
MMP1 |
pg/ml |
serum |
2090 (258 - 14300) |
3350 (249 - 56000) |
0.0226 |
OPN |
pg/ml |
plasma |
4980 (868 - 29600) |
7410 (425 - 297000) |
0.033 |
TNF-alpha |
pg/ml |
serum |
7.55 (1.55 - 13.21) |
7.85 (3.09 - 26.67) |
0.1092 |
TIMP2 |
ng/ml |
serum |
82.5 (59.2 - 106.2) |
77.6 (47.3 - 159.4) |
0.1149 |
CEACAM6 |
ng/ml |
plasma |
1.62 (0.60 - 3.54) |
1.63 (0.60 - 7.99) |
0.1344 |
MIP-1beta |
pg/ml |
serum |
77.00 (37.30 - 369.0) |
66.95 (35.8 - 1510) |
0.1355 |
Dkk3 |
pg/ml |
plasma |
58895 (37232 - 78500) |
56473 (27726 - 75779) |
0.3046 |
ENA-78 |
pg/ml |
serum |
1275 (302 - 5180) |
1240 (264 - 4450) |
0.4717 |
MMP3 |
pg/ml |
serum |
13250 (2280 - 37600) |
11100 (2600 - 55500) |
0.5033 |
TIMP2 |
ng/ml |
plasma |
90.71 (64.06 - 129.7) |
90.86 (53.78 - 172.3) |
0.6593 |
MCP1 |
pg/ml |
serum |
233.5 (80 - 526) |
237.5 (20.3 - 795) |
0.7915 |
MMP8 |
pg/ml |
serum |
8720 (1510 - 21600) |
8190 (1490 - 50600) |
0.9344 |
M30 |
U/L |
serum |
178.8 (85.7 - 500.1) |
173.4 (87.17 - 901.6) |
0.9791 |
|